MedTrace Logo

Glucomen Day Cascade CGM System 21-Day Wear Study

NCT05460260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-07-15

No results posted yet for this study

Summary

Assessment of 21-day CGM wear period

Conditions

  • Efficacy of a 21-Day Wear Period for the Cascade CGM

Interventions

DEVICE

Cascade CGM

21-days of CGM wear

Sponsors & Collaborators

  • WaveForm Technologies Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-12
Primary Completion
2020-09-27
Completion
2020-11-15
FDA Device
Yes

Countries

  • Croatia
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05460260 on ClinicalTrials.gov